-
Name
1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
- EINECS
- CAS No. 302-96-5
- Density 1.129g/cm3
- Solubility
- Melting Point
- Formula C21H32 N2 O
- Boiling Point 490.8°Cat760mmHg
- Molecular Weight 328.498
- Flash Point 250.7°C
- Transport Information
- Appearance
- Safety Human systemic effects by ingestion: jaundice. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
- Risk Codes
-
Molecular Structure
- Hazard Symbols
- Synonyms 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI);Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-(6CI,7CI); 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol; 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol; 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole; 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole; 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole;Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC233046; Stanabolic; Stanazolol; Stanozolol; Stromba; Strombaject; Tevabolin;Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V
- PSA
- LogP
Androstanazol Chemical Properties
Molecule structure of Androstanazol (CAS NO.302-96-5) :
Molecular Weight: 328.49158 g/mol
Molecular Formula: C21H32N2O
Density: 1.129 g/cm3
Boiling Point: 490.8 °C at 760 mmHg
Flash Point: 250.7 °C
Index of Refraction: 1.573
Molar Refractivity: 95.87 cm3
Molar Volume: 290.8 cm3
Polarizability: 38*10-24cm3
Surface Tension: 48.8 dyne/cm
Enthalpy of Vaporization: 79.77 kJ/mol
Vapour Pressure: 1.89E-10 mmHg at 25°C
XLogP3-AA: 4.5
H-Bond Donor: 2
H-Bond Acceptor: 2
Tautomer Count: 2
Exact Mass: 328.251464
MonoIsotopic Mass: 328.251464
Topological Polar Surface Area: 48.9
Heavy Atom Count: 24
Complexity: 538
Defined Atom StereoCenter Count: 7
Canonical SMILES: CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C
Isomeric SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
InChI: InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1
InChIKey: LKAJKIOFIWVMDJ-IYRCEVNGSA-N
Androstanazol Toxicity Data With Reference
| 1. | orl-wmn TDLo:24 mg/kg/17 W-I:SYS | BMJOAE British Medical Journal. 294 (1987),612. | ||
| 2. | orl-man TDLo:4285 mg/kg/30 D-I:SYS | BMJOAE British Medical Journal. 294 (1987),612. |
Androstanazol Safety Profile
Human systemic effects by ingestion: jaundice. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Androstanazol Specification
Androstanazol (CAS NO.302-96-5) is also called 17-Methyl-5alpha-androstano(3,2-c)pyrazol-17beta-ol ; 17-Methyl-pyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol ; 17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole ;
2,3-(4',3'-Pyrazolo)-5alpha-androstan-17beta-ol ; 17-methyl- , NSC 43193 ; Stanozolol ; WIN 14833 ; Winstrol ; Winstrol V . Androstanazol (CAS NO.302-96-5) is a kind of toxic substance. It is flammable. It will produce toxic nitrogen oxide fumes smoke when buring. So the storage environment should be ventilate, low-temperature and dry.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View